Your browser doesn't support javascript.
loading
An engineered bispecific human monoclonal antibody against SARS-CoV-2.
Li, Zhaohui; Li, Shihua; Zhang, Gen; Peng, Weiyu; Chang, Zhen; Zhang, Xue; Fan, Zheng; Chai, Yan; Wang, Feiran; Zhao, Xin; Li, Dedong; Zhang, Rong; He, Zhanlong; Zou, Weiwei; Xu, Ke; Lei, Wenwen; Liu, Peipei; Hao, Junfeng; Zhang, Jingjing; Sun, Litao; Wu, Guizhen; Tan, Shuguang; Gao, George Fu; Gao, Feng; Wu, Yan.
Affiliation
  • Li Z; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Li S; University of Chinese Academy of Sciences, Beijing, China.
  • Zhang G; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Peng W; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Chang Z; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Zhang X; College of Veterinary Medicine, China Agricultural University, Beijing, China.
  • Fan Z; Department of Pathogen Microbiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
  • Chai Y; Department of Pathogen Microbiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
  • Wang F; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Zhao X; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Li D; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Zhang R; School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, China.
  • He Z; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Zou W; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Xu K; College of Veterinary Medicine, China Agricultural University, Beijing, China.
  • Lei W; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Liu P; Laboratory of Animal Infectious Diseases, College of Animal Sciences and Veterinary Medicine, Guangxi University, Nanning, China.
  • Hao J; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
  • Zhang J; Department of Pathogen Microbiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
  • Sun L; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Wu G; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Tan S; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Gao GF; Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Gao F; School of Public Health (Shenzhen), Sun Yat-sen University, Guangzhou, China.
  • Wu Y; School of Public Health (Shenzhen), Sun Yat-sen University, Guangzhou, China.
Nat Immunol ; 23(3): 423-430, 2022 03.
Article in En | MEDLINE | ID: mdl-35228696
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 4_TD Database: MEDLINE Main subject: Antibodies, Bispecific / SARS-CoV-2 / Antibodies, Monoclonal / Antibodies, Viral Limits: Animals / Humans Language: En Journal: Nat Immunol Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 4_TD Database: MEDLINE Main subject: Antibodies, Bispecific / SARS-CoV-2 / Antibodies, Monoclonal / Antibodies, Viral Limits: Animals / Humans Language: En Journal: Nat Immunol Year: 2022 Document type: Article